Capture
PRODUCTS
-
Allogeneic CAR-T Cells Vs Autologous
Chimeric antigen receptor (CAR) T cell therapy has emerged as one of the major breakthroughs in cancer immunotherapy in the last decade. Clinical trials with autologous CAR-T cells have shown very promising results and led to the approval of numerous CAR-T cell therapies.
-
The CliniMACS Prodigy® represents the next generation in automated cell processing. This device offers advanced integrated solutions to streamline cell processing workflows – from cell separation through cell culture to formulation of the final product.
-
StabilityPlus™, phase-stable cable assemblies, are designed for high-performance, ruggedized microwave/RF applications. They offer excellent measurement repeatability and durability, reducing the total cost-of-test.
-
Track and manage defects and non-conformances – such as SOP deviations or missing data – from identification to resolution.
-
This easy-to-use process analytical technology device offers in-line bioprocess analysis and control with no complex modeling. Measure multiple critical parameters across media, across processes, across mammalian cell lines, across scales.
All In-line Gain, No Modeling Pain
MAVERICK is powered by Raman spectroscopy and a purpose-built de novo model. The de novo model is explicitly built on media chemistries and device physics, not on empirical data. It automatically interprets the spectra and quantifies process parameters enabling simultaneous measurements of glucose, lactate, and total biomass. This is achieved without the costs, complexities, and risks associated with conventional Process Analytical Technology (PAT) methods. There is no need to grapple with complex empirical models, reagents, or unreliable auto-sampling systems to implement in-line bioprocess analysis.
WHITE PAPERS AND CASE STUDIES
-
Leading European CDMO For Drug Product Manufacturing
As timelines tighten and regulatory demands grow, discover how a European CDMO delivers integrated solutions from aseptic fill and finish to packaging and release.
-
Keeping The Lights On With Wolfspeed SiC
Introducing the “M” inverter, a modular, silicon carbide-based solution that optimizes utility-scale energy storage with higher efficiency, reliability, and scalability.
-
The EMR Interoperability Dream Vs. Clinical Research Reality
Seamless Electronic Medical Record access promises accelerated trials and regulatory-grade evidence, but incomplete, unstructured data requires hybrid strategies using AI and human oversight to bridge gaps.
-
Vaccine Clinical Trials Global Landscape Whitepaper (2024)
The global vaccine trial landscape is undergoing rapid evolution, driven by technological innovations, emerging health threats, and regulatory shifts.
-
Achieving Complete Destruction Of PFAS Using electraCLEAR Process
In early 2023, Lacks Enterprises Inc., a large automotive component supplier in the midwestern US, engaged Axine to address destruction of legacy PFAS compounds in wastewater from its manufacturing processes.
-
Global Start-Up For Multinational Geographic Atrophy Trial
This partnership allowed a leading biopharmaceutical company to navigate the complexities of a Phase IIb study investigating a novel pegylated RNA adapter for geographic atrophy secondary to dry AMD.
-
2025 Trends In Patient Recruitment: From Disruption To Precision
Explore the four macro trends reshaping the recruitment space in 2025—each grounded in emerging data, technology, and behavior shifts.
-
CDMO Accelerates Contract Manufacturing With Electronic Batch Records
A prominent CDMO sought a specialized software solution to streamline and accelerate its manufacturing processes, enabling the efficient production of complex, customized products in record time.
-
Re-Engineering A Complex Process For FDA Compliance
Discover the strategies that helped a company navigate a complex and shifting regulatory landscape to rapidly re-engineer a COVID-19 vaccine manufacturing process for FDA compliance.
-
Patient Selection By Anti-AAV Total Antibody Binding
Advance the future of medicine by harnessing AAV-based gene therapies — powerful delivery systems that drive safer, more effective, and potentially curative treatments for genetic disorders.
-
How Optics And Flow Cytometry Are Improving Pancreatic Cancer Treatment
The University of Texas researchers are developing an optical system analyzing cancer cell properties to guide treatments, improving patient outcomes and targeting aggressive cancers like pancreatic.
-
Optimized Stability Storage
A healthcare manufacturer facing space constraints and regulatory pressures outsourced their stability storage needs to another company, resulting in reduced costs and focus on core competencies.
NEWS
-
AgozTech LLC Launches Durable Metal Forklift Holder Mounts For Mobile Scanners And Printers8/27/2025
AgozTech, a leading innovator in industrial device accessories, today announced its new line of Metal Holder Mounts for Forklifts, purpose-built to enhance mobile device management in warehouses, distribution centers, and logistics operations.
-
Artificial Intelligence Trained To Spot Black-Grass Growing Amongst Crops11/3/2025
A partnership between Rothamsted with industry partners Bosch, Chafer Machinery, and Xarvio has shared specialist knowledge to bring about an innovative new approach to black-grass control.
-
Bionano Laboratories Announces A Second Category I CPT Code For OGM Established By The AMA; This One For Use In Whole Genome Analysis For Constitutional Genetic Disorders5/19/2025
Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), today announced that the editorial panel of the American Medical Association (AMA) established a new Category I Current Procedural Terminology (CPT®) code for the use of OGM in cytogenomic genome-wide analysis to detect structural and copy number variations related to constitutional genetic disorders.
-
WEROCK Presents Rocktab U212 Pro Rugged Tablet With Large Display9/2/2025
WEROCK Technologies GmbH, innovative manufacturer of rugged tablets, notebooks and mobile data collection devices, presents the Rocktab U212 Pro, a powerful solution for mobile use.
-
Xerafy And ABL Partner To Advance RFID Asset Tracking Software Adoption In Energy, Healthcare, And Manufacturing4/9/2025
Xerafy, a leader in RFID engineering, and ABL, a pioneer in low-code asset tracking software, have joined forces to accelerate digital transformation in asset-intensive industries.